Research in Action: Measuring Patient-Reported Outcomes in FSGS
What are patient-reported outcome measures (PROMs) and why do they matter?
Patient-reported outcome measures (PROMs) are tools to help healthcare providers quantify outcomes that are important to the patient.
For example, your healthcare provider likely monitors your Focal Segmental Glomerulosclerosis (FSGS) by measuring biomarkers in your urine and blood. Certainly, these measures provide important information about disease activity to your provider. However, they do not reflect the impact of FSGS on your general physical, mental, and social health (1). For example, missing work because of fatigue is far more meaningful to you than a lab value in your healthcare chart.
Patient-reported outcome measures provide a missing link. They help healthcare providers understand the impact of living with a disease on terms that matter to you.
Patient-reported outcome measures can be used to improve clinical care for patients, they may guide the development of new treatments, and they can help clinical practices measure and improve the quality of care they provide (2).
PROMs and FSGS
When it comes to the personal experience of managing a health condition, patients or their caregivers are the experts. That’s why researchers perform Patient-Reported Outcome research based on lengthy interviews with a variety of patients. Researchers then analyze themes from these interviews to create disease-specific PRO measures for use in clinical care.
To date, there has been research to develop a Patient Reported Outcomes tool for FSGS.
In one such research study,
55% of the interview time was spent on physical symptoms,
20% of interview time was spent on mental health,
20-25% of interview time was spent on social health.
You might also be surprised to learn that, while some PROMs focus on the negatives of living with FSGS (ex: swelling or pain), there were positive themes that came from interviews as well. One theme focused on the impact of a strong support community and another focused on appreciation for the times of good health.
FSGS-specific PRO tools are still being researched and are not yet used as standards of care for people with FSGS. But even without a standardized tool, you should feel comfortable discussing how FSGS impacts you in daily life with your provider.
Your voice matters in clinical research.
The development of tools such as PROMs is going to help deliver better care for people like you living with FSGS. There are other ways to get involved with research.
References:
(1) Carlozzi NE, Massengill SF, Trachtman Het al. Health-related quality of life in focal segmental glomerular sclerosis and minimal change disease: A qualitative study of children and adults to inform patient-reported outcomes. Kidney Medicine, 2021. P 1 / col 2 / para 1.
(2) Weldring T, and Smith, S. Patient-Reported Outcomes (Pros) and Patient-Reported Outcome Measures (Proms). Health Services Insights. P 63 / col 1 / para 4.
(3) Carlozzi NE, Massengill SF, Trachtman Het al. Health-related quality of life in focal segmental glomerular sclerosis and minimal change disease: A qualitative study of children and adults to inform patient-reported outcomes. Kidney Medicine, 2021. P 498 / poster presentation.
Latest from Know Rare
Discover the latest treatments for IgA Nephropathy (IgAN), a rare kidney disease. Learn how current medications and emerging therapies work to slow progression, reduce proteinuria, and protect kidney function.
Discover how patient education empowers individuals with rare diseases to better understand their diagnosis, make informed decisions, and actively participate in their treatment plans. Learn why clear, compassionate communication is key to improving outcomes in rare disease care.
A heartfelt mother’s account on five years of navigating pediatric specialist waiting rooms with her medically complex child.
A powerful personal journey through Koolen-de Vries syndrome, ADHD, and neurodivergent parenting. Discover how one mother turned diagnosis into empowerment, embracing difference, healing guilt, and raising resilient, remarkable children in a world that doesn’t always understand.
Toni Roberts lives with Epidermolysis Bullosa, a rare genetic disorder that causes the skin to be extremely fragile and prone to blistering and tearing. Toni’s condition profoundly impacted her older sister, Cady Ward. Witnessing Toni’s daily struggles and challenges, Cady was inspired to become an advocate for rare disease and take on an extraordinary challenge—run an ultra-marathon.
Dr. David Fajgenbaum was in his third year of medical school when a rare and mysterious illness derailed his plans. Crushing fatigue, abdominal pain, and multiple swollen lymph nodes progressed rapidly, and he found himself in the ICU with multiple system organ failure. Recovering from the brink of death, he was diagnosed with Castleman disease (CD), a rare condition that at the time was thought to be a lymph node disease with similarities to cancer.
Learn about Dr. Rohit Aggarwal’s efforts in creating more centers of excellence for myositis, as well as educating, empowering, and connecting patients to clinical trials.
Recognizing the need for an effective way to treat becker muscular dystrophy, researchers have been studying the cause of muscle loss, and ways to stop it from happening.
After his diagnosis of limb-girdle muscular dystrophy type 2B at age 21, Chris initially opted for a safe career path, choosing jobs with steady income, benefits, and predictability. However, this decision made him feel like something was missing. Find out how Chris was finally able to follow his heart, finding purpose and contentment in becoming a writer.
Learn more about CureGRIN, founded in 2018 by parents of children diagnosed with GRIN Disorder to help find cures and therapies for people around the world suffering from these conditions.
Learn about the incredible story of Edward Gent, a Sports Nutritionist diagnosed with MMN, who decided to create an app to help others worldwide with their disease and symptom management.
Find out about 7 research areas identified as priorities in Sickle Cell Research and about a sickle cell disease drug, which was originally approved for treatment, that has been taken off the market.
It’s no secret that it is difficult to get to a pain medicine specialist. There are just so many people in pain who cannot find relief, and are looking for help. Learn about Bliss Health, which provides access to pain management services through virtual consultations, through a dedicated team of medical professionals who specialize in the diagnosis, treatment, and ongoing management of various types of chronic and acute pain conditions.
There are over 50 million people in the United States that live with chronic pain. However, researchers studying pain have learned something important: perception of pain is personal, and may have more to do with other factors than just the physical cause of the pain.
If you are coming across high copays and struggling to afford your treatment plan, here are a few options that may help you reduce the costs of your medications.
At age 15, Becca Salky became her own medical detective, playing a key role in uncovering her diagnosis. Now, as a Clinical Research Coordinator at Massachusetts General Hospital, she focuses on spreading awareness about MOG, finding better diagnostic tools, leading clinical trials, and fighting gender disparity.
On the “Rare Insights” podcast we bridge the gap between those living with rare diseases and the biopharmaceutical industry.
Why Men’s Health Week (June 10-16) matters for the Rare Community, and how you can take part.
June is Pride Month, and at Know Rare, we are committed to celebrating the rich diversity within the rare disease community.
Journalist Lindsay Guentzel describes navigating a diagnostic odyssey and how she manages day-to-day life with myositis in an impactful webinar.
When you live with a rare disease, the joyful experiences risks can bring are all the more valuable.
This summer, NMOSD and MOGAD patients, caregivers, clinicians, nurses, researchers, and advocates are invited to join The Sumaira Foundation at Emory for TSF's Atlanta Patient Day.
Know Rare writer Gina DeMillo Wagner’s new memoir, Forces of Nature explores powerful themes related to caregiving and rare disease.
Journalist Lindsay Guentzel offers an inside look at life with the rare muscular condition.
This May, Know Rare is shining a light on myositis, a group of rare autoimmune muscle diseases that can have profound effects on daily life. This is an important time for the myositis community and the rare disease community at large: a time to share stories from those living with the condition, share more information about the current state and future of the disease, and advocate for better treatments that will ultimately enhance the quality of life for those impacted by it. Whether you're a patient, caregiver, or advocate, join us in raising awareness and supporting those affected by myositis.
Author Chris Anselmo explains why being mindful of your pace can have major benefits for your health and well-being, and offers some tips to help.
